Stick with simple antibiotics for pneumonia to avoid super bugs, says researcherAugust 27, 2008Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study Australian hospitals should avoid prescribing expensive broad-spectrum antibiotics for pneumonia to avoid the development of more drug-resistant super bugs, according to a University of Melbourne study. The study, by PhD researcher and Austin Health Infectious Diseases consultant, Dr Patrick Charles, shows that only 5 per cent of people admitted to hospital with community-acquired pneumonia had infections caused by organisms that could not be successfully treated with penicillin combined with an "atypical" antibiotic such as doxycycline or erythromycin.
In the world's largest study of its kind, Dr Charles studied almost 900 people admitted to six Australian hospitals over 28 months from 2004 to 2006. Dr Charles' research analysed samples of blood, urine, sputum and viral swabs of the nose and throat taken from 885 patients at the Austin, Alfred, Monash and West Gippsland hospitals in Victoria, the Royal Perth Hospital and Princess Alexandra Hospital, Brisbane. He found that most cases of pneumonia were caused by easy to treat bacteria such as the pneumococcus or Mycoplasma, or alternatively by respiratory viruses that do not require antibiotic therapy. Only five per cent of cases were caused by organisms that would require more expensive and broad-spectrum antibiotics, and these cases were nearly all in patients who'd had frequent hospital admissions or were residents of nursing homes. "The study results show that current Australian guidelines for prescribing antibiotics for pneumonia are appropriate,'' Dr Charles said. "It shows that Australian doctors should resist the push which is occurring in some parts of the world - particularly the US - to prescribe broad spectrum antibiotics to treat essentially all possible causes." Dr Charles said the trend towards broad-spectrum antibiotics was being driven by laboratory-based studies of resistance rates in bacteria sent to the labs, rather than clinical studies of patients with pneumonia. In the laboratory-based studies, the bacterial isolates often come from highly selected patients with more difficult to treat disease. In addition, the fear of litigation made some doctors unnecessarily opt for more aggressive treatments. However, the more frequently these broad-spectrum antibiotics were used, the more likely it was that bacteria would be become resistant to them. "The emergence of antibiotic-resistant bacterial pathogens is one of the biggest threats to Australian health care standards and is closely linked to the inappropriate use of antibiotics,'' Dr Charles said. "By continuing to use more traditional antibiotics to treat most cases of pneumonia, Australian doctors can limit or delay the emergence of more resistant strains of bacteria. "By using the broad-spectrum antibiotics less often, we can also prolong the effective lifespan of these drugs. "Furthermore, in the US, Canada and some parts of Europe, they are seeing some serious complications which appear to be related to the overuse of some classes of broad-spectrum antibiotics that are frequently used there to treat respiratory infections." University of Melbourne | |||||||||||||||||||||
|
Related Antibiotics Current Events and Antibiotics News Articles Long-term antibiotics reduce COPD exacerbations, raise questions Long-term use of a macrolide antibiotic may reduce the frequency of exacerbations in patients with moderate to severe chronic obstructive pulmonary disease (COPD) by as much as 35 percent, according to a London-based study. Stopping germs from ganging up on humans Keeping germs from cooperating can delay the evolution of drug resistance more effectively than killing germs one by one with traditional drugs such as antibiotics, according to new research from The University of Arizona in Tucson. Biomedical engineers' detective work reveals antibiotic mechanism A series of genetic clues led a team of Boston University biomedical engineers to uncover exactly how certain antibiotics kill bacteria. The findings could help rejuvenate the efficacy of older antibiotics and reveal new antibiotic targets within bacterial cells. Researchers aim to over-stress already taxed mantle cell lymphoma cells Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them. Battling bacteria in the blood: Researchers tackle deadly infections It's a leading cause of death, but no one knows for sure how and why it happens. It's a major source of health care costs, adding days or weeks to the hospital stays and lost work time of millions of people. But no one fully understands how best to fight it. MU Study Identifies Patient Strategies for Managing Symptoms of Lymphedema An estimated 2 million women in the United States are at risk of developing lymphedema, a condition that involves the chronic and abnormal swelling of the arm, chest, neck and/or back, as a complication of breast cancer treatment. Researchers find new chemical key that could unlock hundreds of new antibiotics Chemistry researchers at The University of Warwick and the John Innes Centre, have found a novel signalling molecule that could be a key that will open up hundreds of new antibiotics unlocking them from the DNA of the Streptomyces family of bacteria. How to treat pelvic sepsis after stapled hemorrhoidopexy? In the last decade, stapled hemorrhoidopexy has become increasingly popular and is indicated for the treatment of symptomatic hemorrhoids grade 3 and 4. Stapled hemorrhoidopexy does not remove the hemorrhoids, but it is rather a strip of mucosa and submucosa at the top of the hemorrhoids. Researchers downplay MRSA screening as effective infection control intervention Three Virginia Commonwealth University epidemiologists are downplaying the value of mandatory universal nasal screening of patients for MRSA, arguing that proven, hospital-wide infection control practices can prevent more of the potentially fatal infections. Genes that control cell death fingered in age-related hearing loss Several genes that play a role in how our body's cells normally auto-destruct may play a role in age-related hearing loss, according to research published online in the journal Apoptosis - a journal devoted to the topic of cell suicide, or programmed cell death. More Antibiotics Current Events and Antibiotics News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||